Did you mean 3,4 2,3 3?
Displaying drugs 8901 - 8925 of 11124 in total
t-Butylhydroquinone
Experimental
Matched Synonyms: … 2-t-Butylhydroquinone ... 2-t-Butyl-1,4-benzenediol ... 2-tert-butylhydroquinone …
Matched Iupac: … 2-tert-butylbenzene-1,4-diol …
Matched Iupac: … 2-tert-butylbenzene-1,4-diol …
Epratuzumab
Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.
Investigational
Matched Description: … Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2) …
rAAVrh74.MCK.GALGT2
Investigational
S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE
Experimental
Matched Iupac: … 4,5,6,7-tetrabromo-2-(methylsulfanyl)-1H-1,3-benzodiazole …
Naphthalene-2,6-disulfonic acid
Experimental
Amrubicin
Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January...
Investigational
Matched Iupac: … (7S,9S)-9-acetyl-9-amino-7-{[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy}-6,11-dihydroxy-5,7,8,9,10,12-hexahydrotetracene …
Matched Description: … In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both …
Matched Salts cas: … 110311-30-3 …
Matched Description: … In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both …
Matched Salts cas: … 110311-30-3 …
Garetosmab
Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of episodic, progressive heterotropic ossification. FOP is characterized by episodic inflammatory episodes, which may be precipitated by trauma, including immunizations and minor tissue damage, which usually result in ossification of the lesion. Patients experience abnormal cartilage formation, growth plate dysplasia,...
Investigational
Maleic acid
Experimental
Matched Synonyms: … (Z)-2-butenedioic acid ... cis-but-2-enedioic acid …
Matched Iupac: … (2Z)-but-2-enedioic acid …
Matched Iupac: … (2Z)-but-2-enedioic acid …
2-(N-morpholino)ethanesulfonic acid
Experimental
Matched Synonyms: … 2-(4-morpholinyl)ethanesulfonic acid ... 2-morpholinoethanesulphonic acid ... 2-(N-morpholino)ethanesulfonic acid …
Matched Name: … 2-(N-morpholino)ethanesulfonic acid …
Matched Iupac: … 4-(2-sulfonatoethyl)morpholin-4-ium …
Matched Name: … 2-(N-morpholino)ethanesulfonic acid …
Matched Iupac: … 4-(2-sulfonatoethyl)morpholin-4-ium …
7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate
Experimental
Matched Name: … 7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate …
Matched Iupac: … {[(2R,3S,4R,5S)-3,4-dihydroxy-5-(7H-purin-7-yl)oxolan-2-yl]methoxy}phosphonic acid …
Matched Iupac: … {[(2R,3S,4R,5S)-3,4-dihydroxy-5-(7H-purin-7-yl)oxolan-2-yl]methoxy}phosphonic acid …
6-Hydro-1-Methyladenosine-5'-Monophosphate
Experimental
Matched Name: … 6-Hydro-1-Methyladenosine-5'-Monophosphate …
Matched Iupac: … {[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolan-2-yl]methoxy}phosphonic …
Matched Iupac: … {[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolan-2-yl]methoxy}phosphonic …
Pyridoxyl-Glutamic Acid-5'-Monophosphate
Experimental
Matched Name: … Pyridoxyl-Glutamic Acid-5'-Monophosphate …
Matched Iupac: … 4-({[(1S)-1,3-dicarboxypropyl]amino}methyl)-3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-1-ium …
Matched Iupac: … 4-({[(1S)-1,3-dicarboxypropyl]amino}methyl)-3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-1-ium …
25-desacetylrifapentine
25-desacetylrifapentine is under investigation in clinical trial NCT00023387 (TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine).
Investigational
Temafloxacin
Temafloxacin is an antibiotic agent belonging to the fluoroquinolone drug class. It was first approved for use in the U.S. market in 1992, but was withdrawn shortly due to the reports of serious adverse reactions, such as allergic reactions and hemolyric anemia, resulting in three deaths.
Withdrawn
Matched Iupac: … 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Fleroxacin
Fleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase. Fleroxacin is not an inhibitor of CYP1A2.
Experimental
Matched Iupac: … 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Difloxacin
Difloxacin is a synthetic fluoroquinolone used in veterinary. As an antibacterial, it presents a broad bactericidal spectrum and its effects are dependent on its concentration. However, it presents a reduced efficacy when compared to other fluoroquinolone antibacterials.
Vet approved
Matched Iupac: … 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Salts cas: … 91296-86-5 …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Salts cas: … 91296-86-5 …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Pradofloxacin
Pradofloxacin is a 3rd generation fluoroquinolone antibiotic developed by Bayer HealthCare AG, Animal Health GmBH. It was approved by the European Commission in April 2011 for bacterial infections in dogs and cats.
Vet approved
Matched Iupac: … -octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3- …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Zamtocabtagene autoleucel
Investigational
2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose
Experimental
Matched Name: … 2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose …
Matched Iupac: … (3aR,4R,5R,6R,6aS)-6-(hydroxymethyl)-2-(methylideneamino)-3aH,4H,5H,6H,6aH-cyclopenta[d][1,3]oxazole- …
Matched Iupac: … (3aR,4R,5R,6R,6aS)-6-(hydroxymethyl)-2-(methylideneamino)-3aH,4H,5H,6H,6aH-cyclopenta[d][1,3]oxazole- …
(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM
Experimental
Matched Iupac: … [2-(dodecyldimethylphosphaniumyl)-1-phosphonoethyl]phosphonic acid …
(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE
Experimental
Matched Iupac: … -1(11),3(8),4,6,9,12,14-heptaene ... (2S)-13-chloro-2-(1-methanesulfonylpiperidin-4-yl)-10-(piperazin-1-yl)-4-azatricyclo[9.4.0.0^{3,8}]pentadeca …
2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid
Experimental
Matched Name: … 2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid …
Matched Iupac: … 2-(1-carboxy-N-{4-[(2S)-2-acetamido-2-(pentylcarbamoyl)ethyl]naphthalen-1-yl}formamido)benzoic acid …
Matched Iupac: … 2-(1-carboxy-N-{4-[(2S)-2-acetamido-2-(pentylcarbamoyl)ethyl]naphthalen-1-yl}formamido)benzoic acid …
Ecromeximab
Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.
Investigational
Phosphocysteamine
Investigational
Matched Synonyms: … S-(2-aminoethyl) phosphorothioate ... Ethanethiol, 2-amino-, 1-(dihydrogen phosphate) ... Phosphorothioic acid, s-(2-aminoethyl) ester …
Matched Iupac: … [(2-aminoethyl)sulfanyl]phosphonic acid …
Matched Iupac: … [(2-aminoethyl)sulfanyl]phosphonic acid …
Displaying drugs 8901 - 8925 of 11124 in total